Early efforts concentrated on intestinal disorders such as inflammatory bowel disease (IBD), where genetically modified Lactococcus lactis was engineered to produce the anti-inflammatory cytokine interleukin-10 (IL-10) in the gut. Here, IL10 is linked to irritable bowel syndrome.